# SB 449: Relating to warning labels for opioid prescription drugs.

90th Legislature (90R) · Senate · Status: Filed

Record current as of: the Legislative Council last updated this bill's record 11/20/2026 2:00:17 AM; this site copied it 2026-11-21T22:18:17.720605Z.

How to read this page: **Official record** is copied unchanged from the Texas Legislative Council's bill files, the data behind Texas Legislature Online. **Computed by this site** is worked out by fixed rules from that record. **AI analysis (Luna)** is written by an AI model that read the bill text; it can be wrong, so check it against the bill text.

## Official record

Source: Texas Legislative Council bill files (ftp.legis.state.tx.us), copied unchanged.

- Filed: 2026-11-19
- Most recent action: 2026-11-19 · Senate: Filed
- Official subjects (Legislative Council index): Crimes--Drugs; Occupational Regulation--Health Occupations; MEDICINE & PRESCRIPTION DRUGS; PACKAGING & LABELING REQUIREMENTS; PHARMACY, TEXAS STATE BOARD OF
- Companion bills: none listed in the source data

### Caption

Relating to warning labels for opioid prescription drugs.

### Bill text

The official wording of each version, copied from the Texas Legislative Council's bill text files and converted to Markdown with the wording unchanged. Language the bill adds is marked <ins>like this</ins>; language it removes is in [<del>brackets</del>]. To check a copy, fetch the official file and compare its SHA-256 with the one listed; the copy's own SHA-256 confirms you received it unaltered.

- Introduced: https://billatlas.org/live/text/SB449/I.md
  - Official file: ftp://ftp.legis.state.tx.us/bills/90R/billtext/HTML/senate_bills/SB00400_SB00499/SB00449I.HTM, last modified 2026-11-19 20:26:16 UTC, SHA-256 86328392f6aff52d09fb64f8f12c76427e75655d8c58f06eb1c9074b29c7bdc5
  - This copy: made 2026-11-19T21:18:48.681914Z, SHA-256 of the Markdown 00cde696c9828c962d19f9841020b034164c71f30af3bfbfa12c4d5a18089860

#### Text of the latest version (Introduced)

````markdown
# SB 449 - Introduced

90R675 RDR-D

By: Hall S.B. No. 449

A BILL TO BE ENTITLED

AN ACT

relating to warning labels for opioid prescription drugs.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

### SECTION 1.

Section 481.074(a), Health and Safety Code, is amended to read as follows:

(a) A pharmacist may not:

(1) dispense or deliver a controlled substance or cause a controlled substance to be dispensed or delivered under the pharmacist's direction or supervision except under a valid prescription and in the course of professional practice;

(2) dispense a controlled substance if the pharmacist knows or should have known that the prescription was issued without a valid patient-practitioner relationship;

(3) fill a prescription that is not prepared or issued as prescribed by this chapter;

(4) permit or allow a person who is not a licensed pharmacist or pharmacist intern to dispense, distribute, or in any other manner deliver a controlled substance even if under the supervision of a pharmacist, except that after the pharmacist or pharmacist intern has fulfilled his professional and legal responsibilities, a nonpharmacist may complete the actual cash or credit transaction and delivery; \[<del>or</del>\]

(5) permit the delivery of a controlled substance to any person not known to the pharmacist, the pharmacist intern, or the person authorized by the pharmacist to deliver the controlled substance without first requiring identification of the person taking possession of the controlled substance, except as provided by Subsection (n)<ins>; or</ins>

<ins>(6) dispense an opioid unless the bottle or container in which the opioid is dispensed is affixed with a label warning of the addictive nature of opioids and the risks of respiratory depression and overdose as required by board rule under Section 481.0761(l)</ins>.

### SECTION 2.

Section 481.0761, Health and Safety Code, is amended by adding Subsection (l) to read as follows:

<ins>(l) The board shall adopt rules requiring that an opioid be dispensed in a bottle or container affixed with a label warning users of the addictive nature of opioids and the risks of respiratory depression and overdose. The label must include language substantially similar to the following:</ins>

<ins>"CAUTION: Opioid. Risk of Addiction, Respiratory Depression, and Overdose."</ins>

### SECTION 3.

The Texas State Board of Pharmacy shall adopt the rules required under Section 481.0761(l), Health and Safety Code, as added by this Act, not later than January 1, 2028.

### SECTION 4.

The change in law made by this Act applies only to a prescription for an opioid dispensed on or after March 1, 2028. A prescription dispensed before March 1, 2028, is governed by the law in effect immediately before the effective date of this Act, and the former law is continued in effect for that purpose.

### SECTION 5.

This Act takes effect immediately if it receives a vote of two-thirds of all the members elected to each house, as provided by Section 39, Article III, Texas Constitution. If this Act does not receive the vote necessary for immediate effect, this Act takes effect September 1, 2027.
````

### Current law this bill changes

Each section as it stands now, from this site's copy of the Texas Legislative Council's statute files (wording unchanged); the official page is the authority. Sections are matched automatically from the bill text and can be missed, for example when a bill changes a whole chapter at once.

- Health and Safety Code §481.074 (amended): Sec. 481.074. PRESCRIPTIONS.
  - This copy (whole chapter): https://billatlas.org/live/law/HS/481.md, copied 2026-11-21T02:14:24.675852+00:00, SHA-256 of the Markdown d88e42c8511bd2b5fd246658e3abef210995a2c465a508e4109b0362a0077069
  - Official: https://statutes.capitol.texas.gov/Docs/HS/htm/HS.481.htm
- Health and Safety Code §481.0761 (amended): Sec. 481.0761. RULES; AUTHORITY TO CONTRACT.
  - This copy (whole chapter): https://billatlas.org/live/law/HS/481.md, copied 2026-11-21T02:14:24.675852+00:00, SHA-256 of the Markdown d88e42c8511bd2b5fd246658e3abef210995a2c465a508e4109b0362a0077069
  - Official: https://statutes.capitol.texas.gov/Docs/HS/htm/HS.481.htm

### Authors and sponsors

Authors and coauthors serve in the originating chamber; sponsors and cosponsors in the other chamber. Authorship does not indicate a vote or caucus position.

#### Authors

- Bob Hall (Republican · SD 2 · 12 years served · since 2015) · [bills](https://agent.billatlas.org/authors/senate-hall.md)

_No coauthors, sponsors or cosponsors listed: no bill in this snapshot lists any yet, so this reflects the stage of the source data, not this bill._

### Recorded actions

1. 2026-11-19: Received by the Secretary of the Senate
2. 2026-11-19: Filed

## Computed by this site

Worked out by fixed rules from the official record above; not a statement by the Legislature.

- Status: Filed
- Most recent action type: Filed
- Hearing status: No hearing yet. No committee referral or hearing has been verified. A likelihood estimate would be premature.
- Authorship: Republican author. Authors: 1 Republican
- Author prominence: Senior author. 12 years in the Senate

## AI analysis (Luna)

Written by Luna, an AI model that reads the full bill text. It can be wrong; the bill text above is the authority. Tags marked caption-rules come from keyword rules applied to the caption, not from the AI.

### Summary

Reviewed 2026-11-19T21:35:23Z · introduced text. Fields from the full text: topics, agencies, impacts, constituencies, locations; other fields use caption inference.

SB 449 would amend Texas controlled-substance dispensing law to prohibit dispensing an opioid unless its bottle or container carries a warning about addiction, respiratory depression, and overdose, using language substantially similar to the specified caution. It would require the Texas State Board of Pharmacy to adopt implementing rules, and the new dispensing requirement would apply only to opioid prescriptions dispensed on or after March 1, 2028.

### Topics

- Healthcare

### Potentially affected agencies

Possible links are rule or model inferences, not confirmed legal obligations.

- **Texas State Board of Pharmacy** (direct, luna-full-text): The bill directly requires the Board to adopt rules implementing the opioid warning-label requirement.

### Types of impact

- Opioid warning-label dispensing requirement
- Pharmacy Board rules

### People and institutions affected

- Pharmacists dispensing opioids
- People who use opioid prescriptions

### Locations

- Texas (statewide): The proposed dispensing requirement applies statewide to opioid prescriptions covered by the bill.

## Links

- Full bill text (official wording, Markdown): https://billatlas.org/live/text/SB449/I.md
- Official bill history: https://capitol.texas.gov/BillLookup/History.aspx?LegSess=90R&Bill=SB449
- Official bill text (every version, HTML/PDF/Word): https://capitol.texas.gov/BillLookup/Text.aspx?LegSess=90R&Bill=SB449
- Open in the tracker: https://billatlas.org/bill/SB449
- RSS feed of actions: https://billatlas.org/live/feeds/SB449.xml
- This page as JSON: https://agent.billatlas.org/bills/SB449.json
- Search all bills: https://agent.billatlas.org/search?q= followed by your words, e.g. https://agent.billatlas.org/search?q=Healthcare

---
Unofficial, independent open-source project; not a state website. The official record and bill text on this page are copied unchanged from the Texas Legislative Council bill files, refreshed hourly, so they can trail the Legislature by up to an hour or two. Computed fields and the AI analysis can be wrong. Not legal advice. For anything that matters, confirm on Texas Legislature Online.
